DK0651806T3 - Vacciner imod katteimmundeficiensvirus (FIV) - Google Patents

Vacciner imod katteimmundeficiensvirus (FIV)

Info

Publication number: DK0651806T3
Authority: DK; Denmark
Prior art keywords: fiv; vaccines against; immunodeficiency virus; against cat; cat immunodeficiency
Prior art date: 1992-07-17

Application number

DK93915919T

Other languages

English (en)

Inventor

Albertus Dominicus M Osterhaus

Cornelis Herman Joha Siebelink

Original Assignee

Mallinckrodt Veterinary Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-17

Filing date

1993-07-15

Publication date

1999-01-25

1993-07-15 Application filed by Mallinckrodt Veterinary Inc filed Critical Mallinckrodt Veterinary Inc

1999-01-25 Application granted granted Critical

1999-01-25 Publication of DK0651806T3 publication Critical patent/DK0651806T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK93915919T 1992-07-17 1993-07-15 Vacciner imod katteimmundeficiensvirus (FIV) DK0651806T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929215232A GB9215232D0 (en)	1992-07-17	1992-07-17	Vaccines
PCT/EP1993/001860 WO1994002612A1 (en)	1992-07-17	1993-07-15	Anti-feline immunodeficiency virus (fiv) vaccines

Publications (1)

Publication Number	Publication Date
DK0651806T3 true DK0651806T3 (da)	1999-01-25

Family

ID=10718887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93915919T DK0651806T3 (da)	1992-07-17	1993-07-15	Vacciner imod katteimmundeficiensvirus (FIV)

Country Status (11)

Country	Link
EP (1)	EP0651806B1 (da)
JP (2)	JPH08500244A (da)
AT (1)	ATE166390T1 (da)
AU (1)	AU4569293A (da)
DE (1)	DE69318716T2 (da)
DK (1)	DK0651806T3 (da)
ES (1)	ES2118242T3 (da)
GB (1)	GB9215232D0 (da)
GR (1)	GR3027636T3 (da)
WO (1)	WO1994002612A1 (da)
ZA (1)	ZA935117B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69535125T2 (de) *	1994-04-29	2007-08-30	Pharmacia & Upjohn Co. Llc, Kalamazoo	Impfstoff gegen felines immunodefizienz-virus
US5820869A (en) *	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US6300118B1 (en)	1995-06-07	2001-10-09	American Home Products Corporation	Plasmids comprising a genetically altered feline immunodeficiency virus genome
US5849303A (en) *	1995-06-07	1998-12-15	American Home Products Corporation	Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
DE602004021829D1 (de)	2003-09-11	2009-08-13	Idexx Lab Inc	Verfahren zum nachweis des felinen immunschwächevirus
DE602004021724D1 (de)	2003-12-18	2009-08-06	Idexx Lab Inc	Verfahren zum nachweis des felinen immunschwächevirus
CA2556141A1 (en)	2004-02-19	2005-09-01	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
CA2576902C (en)	2004-06-30	2012-05-08	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
CA2576930C (en)	2004-06-30	2011-06-07	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en)	2005-03-09	2007-11-06	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
EP2553452B1 (en)	2010-04-02	2015-03-04	IDEXX Laboratories, Inc.	Detection of feline immunodeficiency virus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2669338A1 (fr) *	1990-11-21	1992-05-22	Centre Nat Rech Scient	Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) *	1991-02-28	2001-05-08	Aquila Biopharmaceuticals, Inc.	Recombinant FIV glycoprotein 160 and P24 gag protein

1992
- 1992-07-17 GB GB929215232A patent/GB9215232D0/en active Pending
1993
- 1993-07-15 ZA ZA935117A patent/ZA935117B/xx unknown
- 1993-07-15 AT AT93915919T patent/ATE166390T1/de not_active IP Right Cessation
- 1993-07-15 AU AU45692/93A patent/AU4569293A/en not_active Abandoned
- 1993-07-15 DK DK93915919T patent/DK0651806T3/da active
- 1993-07-15 ES ES93915919T patent/ES2118242T3/es not_active Expired - Lifetime
- 1993-07-15 JP JP6503919A patent/JPH08500244A/ja active Pending
- 1993-07-15 EP EP93915919A patent/EP0651806B1/en not_active Expired - Lifetime
- 1993-07-15 WO PCT/EP1993/001860 patent/WO1994002612A1/en active IP Right Grant
- 1993-07-15 DE DE69318716T patent/DE69318716T2/de not_active Expired - Fee Related
1998
- 1998-08-12 GR GR980401814T patent/GR3027636T3/el unknown
2008
- 2008-07-11 JP JP2008181260A patent/JP2009005706A/ja active Pending

Also Published As

Publication number	Publication date
EP0651806B1 (en)	1998-05-20
ES2118242T3 (es)	1998-09-16
ZA935117B (en)	1994-02-08
JP2009005706A (ja)	2009-01-15
DE69318716D1 (de)	1998-06-25
AU4569293A (en)	1994-02-14
DE69318716T2 (de)	1998-09-10
ATE166390T1 (de)	1998-06-15
GR3027636T3 (en)	1998-11-30
EP0651806A1 (en)	1995-05-10
JPH08500244A (ja)	1996-01-16
GB9215232D0 (en)	1992-09-02
WO1994002612A1 (en)	1994-02-03

Similar Documents

Publication	Publication Date	Title
LV5288A3 (lv)	1993-10-10	Nukleinskabes fragments kurs kode cilveka proapolipoproteinu A-1
DK288183A (da)	1983-06-22	Fremgangsmaade til fremstilling af et oligonucleotidt terapeutisk middel
DE69131321D1 (de)	1999-07-15	Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen
ES8500322A1 (es)	1984-10-01	Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DK0640133T3 (da)	2000-12-18	Rekombinante DNA-molekyler, der koder for aminopeptidaseenzymer og deres anvendelse i fremstillingen af vacciner mod helmin
ES8800266A1 (es)	1987-11-01	Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
DK0651806T3 (da)	1999-01-25	Vacciner imod katteimmundeficiensvirus (FIV)
DK491487A (da)	1988-03-20	Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
NO177570C (no)	1995-10-11	Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
DE59611486D1 (de)	2008-12-11	Retrovirus aus der HIV-Gruppe und dessen Verwendung
ES2059330T3 (es)	1994-11-16	Un cdna codificador de antigeno carcinoembrionico.
FI961202A0 (fi)	1996-03-14	Grb3-3-geeni, sen variantteja ja niiden käyttöjä
DE3881023D1 (de)	1993-06-17	Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE59109072D1 (de)	1999-01-07	Klonierung der N-Methylhydantoinase
IL75553A (en)	1993-07-08	Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
AU5315790A (en)	1990-10-18	Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p. falciparum at the sporozoite stage and in the hepatocytes
ATE87977T1 (de)	1993-04-15	Herstellung menschlichen somatomedins c.
ES2059801T3 (es)	1994-11-16	Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
NO895154L (no)	1989-12-20	Fremgangsmaate ved fremstilling av et protein eller polypeptid, en dna-sekvens som koder for polypeptidet, en mikroorganisme som inneholder dna-sekvensen samt polypeptidet ogdets anvendelse som et farmasoeytisk preparat.